Archives

by in
Entry Author Date Location
AbbVie Plunks Down $275M Upfront for Infinity’s Blood Cancer Drug 09/03/14 Boston
Gilead Edges Into Cancer Field With FDA OK of Calistoga Drug 07/23/14 San Francisco
Gilead Seeks FDA OK for Lymphoma Drug, First Big Move into Cancer 09/11/13 San Francisco
Former Keryx Exec’s Mission: Turn TG Into the Next Pharmacyclics 05/06/13 New York
Gilead Sciences Building on HIV, Becoming Cancer Drug Force 04/01/13 National
Infinity Pharmaceuticals Bounces Back To Compete in Crowded Field 02/08/13 Boston
Millennium, Metamark, Amgen, & More Boston Life Sciences Headlines 12/23/11 Boston
Infinity Pharmaceuticals Snags $50M Extension From Mundipharma 11/29/11 Boston
Encouraged by Early Work on Anti-Cancer Drug, Intellikine Hires New Head for Clinical Trials 07/18/11 San Diego
Oncothyreon Starts Phase 2 Trial 04/05/11 Seattle
Gilead Pursues Cancer, Inflammation as Next Step To Diversify Beyond HIV 02/23/11 San Francisco
Gilead Buys Calistoga Pharma for $375M, Making Move Into Cancer Drugs 02/22/11 Seattle
Oncothyreon Secures $12.5M Loan 02/09/11 Seattle
Calistoga Rolls Out More Evidence For Blood Cancer Drug, Sizes Up Pivotal Trial 12/05/10 Seattle
Exelixis Seeks to Climb From the Penalty Box, Prove its Lead Drug Still Has Legs 10/20/10 San Francisco
Nodality Nears Market With Technology to Get the Right Cancer Drug to the Right Patients 09/16/10 San Francisco
AlloCure Arrives in New England, Merck Shutters Cambridge Research Site, Infinity Cuts Deal With Intellikine, & More Boston-Area Life Sciences News 07/09/10 Boston
Calistoga Pharmaceuticals Builds Stronger Case for Blood Cancer Drug 06/07/10 Seattle
Oncothyreon CEO on Next-Generation Cancer Vaccines, Two Key Zymonites, and Serious Luck 12/23/09 Seattle
Intellikine, Stocked With Cash, Pushes Portfolio of Drugs Against Biology’s Hot Targets 08/18/09 San Diego
Intellikine, Chasing Hot Cancer Drug Target, Raises Big Venture Round 07/02/09 San Diego
Cell Therapeutics Shares Boom, Vulcan’s Breast Cancer Bombshell, Microsoft Buys Rosetta Assets, & More Seattle-Area Life Sciences News 06/04/09 Seattle
ASCO Weekend Recap: OncoGenex, Seattle Genetics, Vulcan-Backed BiPar Show Off Cancer Drug Results 06/01/09 Seattle
Calistoga Picks Up Buzz at ASCO, Thanks to Momentum from Rival 05/30/09 Seattle
Oncothyreon Raises $11M 05/20/09 Seattle
ASCO Preview: Seattle Genetics, ZymoGenetics, Trubion & Other Seattle Biotechs Offer Peeks at Cancer Drug Results 05/15/09 Seattle
Calistoga Raises $30M to Develop Drugs for Cancer, Inflammation 05/05/09 Seattle
Goodbye Cancer Vaccines, Hello Cancer Drugs: Oncothyreon Reinvents Itself 03/31/09 Seattle
Qwell Pharmaceuticals, Backed by Arch, Raises $7M for New Cancer, Inflammation Drugs 01/06/09 Seattle
Calistoga Drug Shrinks Tumors in Lab Studies 12/09/08 Seattle
Page 1 of 2 next page »